1700066C05Rik Inhibitors
1700066C05Rik Inhibitors refers to a class of chemical compounds that have been identified or designed to modulate the activity or function of the protein encoded by the gene 1700066C05Rik. These inhibitors are developed for research purposes and are characterized by their ability to interact with the target protein, either directly or indirectly, resulting in a change in its activity or downstream effects within cellular pathways. It's important to note that the designation of inhibitors indicates the primary function of these compounds, which is to reduce or hinder the normal function of the protein, often to study its role in various biological processes.
These inhibitors can vary widely in their chemical structures and mechanisms of action. They may include small molecules that can bind to specific sites on the protein, interfering with its function, or compounds that influence the regulatory pathways associated with 1700066C05Rik indirectly. The development and characterization of such inhibitors are essential tools in molecular and cellular biology research, allowing scientists to investigate the protein's function, its involvement in signaling pathways, and its impact on cellular processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor, which has shown to affect downstream signaling pathways that could indirectly influence the function of 1700066C05Rik. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $150.00 $388.00 | 113 | |
Broad-spectrum kinase inhibitor, capable of modulating multiple signaling pathways, which indirectly impact the activity of 1700066C05Rik. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor, which has shown to influence the PI3K/AKT pathway, which intersect with pathways involving 1700066C05Rik. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAP kinase inhibitor, which has shown to influence stress response pathways that intersect with the functions of 1700066C05Rik. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor, known to impact gene expression and chromatin structure, which indirectly affect the regulation of 1700066C05Rik. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Proteasome inhibitor, capable of altering the degradation of proteins, which has shown to affect the stability of proteins involved with 1700066C05Rik. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $109.00 $350.00 | 8 | |
Modulates degradation of specific transcription factors, which has shown to impact gene regulation involving 1700066C05Rik indirectly. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $206.00 $299.00 $485.00 | 10 | |
PARP inhibitor, influencing DNA repair mechanisms, which indirectly impact gene expression patterns involving 1700066C05Rik. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $56.00 $212.00 $764.00 | 24 | |
Stabilizes p53, which can lead to changes in gene expression and cellular stress responses, which has shown to affect processes involving 1700066C05Rik indirectly. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
HDAC inhibitor, similar to Trichostatin A, impacting gene expression and regulatory mechanisms associated with 1700066C05Rik. | ||||||